Photo of Anuj Pethia

Partner in the Capital Markets Practice at the Mumbai office of Cyril Amarchand Mangaldas. Anuj has over 10 years of experience in capital markets and has acted on number of initial and follow-on public offerings, rights offerings, qualified institutional placements, institutional placement programs, ADR/GDR, FCCB and bonds offerings, MTN programs, bulk/block trades and buybacks. He joined the firm soon after his graduation in 2008 and he also holds an LL.M. form the Columbia University School of Law, New York. Anuj has been recognised as a “Notable Practitioner” for Capital Markets by the IFLR 1000 (2020) rankings. He can be reached at anuj.pethia@cyrilshroff.com

SEBI CONSULTATION PAPER FOR LISTED COMPANIES WITH STRESSED ASSETS - CURE FOR THE SICK COULD BE VACCINE FOR ALL 

With the slowdown in the economy and unprecedented business disruption due to Covid 19, several Indian listed companies, which were already heavily leveraged, will soon be looking at avenues for further funding to meet working capital requirements and liquidity challenges. Given the current regulatory regime surrounding raising of equity capital, it is possible that some of the over-leveraged ones may become insolvent. With a view to facilitate fund raising by such listed companies that have stressed assets, the market regulator has come up with a consultation paper, that provides certain procedural relaxations to the SEBI (Issue of Capital and Disclosures Requirements) Regulations, 2018 (ICDR Regulations) and SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (SAST Regulations).
Continue Reading SEBI Consultation Paper For Listed Companies With Stressed Assets – Cure For The Sick Could Be Vaccine For All